The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatment
Hoai Phuong T. Pham, Resmi Gupta, John Lindsey
Topics & Concepts
OcrelizumabMedicineELISPOTImmunologyImmune systemMultiple sclerosisAntigenPeripheral blood mononuclear cellVirusInterferonRituximabVirologyAntibodyT cellBiologyIn vitroBiochemistryMultiple Sclerosis Research StudiesViral-associated cancers and disordersPolyomavirus and related diseases